SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 220.16 |
| Enterprise Value ($M) | 474.79 |
| Book Value ($M) | 207.67 |
| Book Value / Share | 4.28 |
| Price / Book | 1.06 |
| NCAV ($M) | 27.83 |
| NCAV / Share | 0.57 |
| Price / NCAV | 7.91 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.42 |
| Return on Assets (ROA) | -0.49 |
| Return on Equity (ROE) | -0.75 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 8.68 |
| Current Ratio | 8.85 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 651.85 |
| Assets | 831.69 |
| Liabilities | 624.02 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 15.84 |
| Operating Income | -281.47 |
| Net Income | -308.48 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -145.93 |
| Cash from Investing | -205.69 |
| Cash from Financing | 362.72 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Nantahala Capital Management, LLC | 6.60 | -18.77 | |
| 13G | Vestal Point Capital, LP | 8.20 | ||
| 13G/A | Fmr Llc | 0.10 | -98.19 | |
| 13G/A | State Street Corp | 7.28 | 28.00 | |
| 13G/A | BlackRock Inc. | 3.60 | -65.22 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 81,633 | 325,895 | 25.05 | |
| 114,269 | 494,483 | 23.11 | |
| 147,933 | 136,219 | 108.60 | |
| 49,990 | 94,060 | 53.15 | |
| 42,726 | 90,089 | 47.43 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PYXS – Pyxis Oncology, Inc. | QDEL – QuidelOrtho Corporation |
| QNCX – Quince Therapeutics, Inc. | RARE – Ultragenyx Pharmaceutical Inc. |
| RDUS – Radius Recycling, Inc. |
Financial data and stock pages provided by
Fintel.io